Autologous γδT cell therapy (302 Military Hospital of China)

N/A

Report date: 2024/11/20 20:00:31

Base Information

Drug NameAutologous γδT cell therapy (302 Military Hospital of China)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesNo 302 Hospital Of The People Liberation Army Of China
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNo 302 Hospital Of The People Liberation Army Of China
Active IndicationsN/A
Inactive IndicationsCarcinoma, Hepatocellular

Other Information

ATC CodeN/A
Related LinksN/A